EBS
Emergent Biosolutions Inc
6.80$
-3.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.1% | 44.3% | 49.9% | 49.4% | 59.0% | 56.3% | 45.3% | 55.3% | 57.7% | 65.7% | 64.0% | 52.8% | |
| 48.9% | 55.7% | 50.1% | 50.6% | 41.0% | 43.7% | 54.7% | 44.7% | 42.3% | 34.3% | 36.0% | 47.2% | |
| 25.9% | 24.4% | 21.9% | 17.4% | 18.3% | 20.5% | 15.1% | 13.3% | 16.9% | 10.6% | 6.8% | 7.2% | |
| 30.4% | 30.3% | 29.4% | 25.6% | 25.9% | 24.7% | 19.2% | 19.6% | 30.5% | 35.5% | 29.5% | 25.1% | |
| 26.8% | 26.8% | 28.5% | 28.4% | 29.5% | 33.4% | 26.9% | 25.5% | 57.5% | 103.5% | 46.4% | 32.4% | |
| 22.1% | 28.9% | 21.6% | 22.2% | 11.5% | 10.3% | 27.8% | 19.2% | -15.2% | -69.2% | -10.4% | 14.8% | |
| 2.0% | 1.3% | 1.6% | 1.2% | 1.3% | 3.5% | 2.0% | 1.9% | 3.3% | 8.4% | 6.8% | 8.0% | |
| 20.8% | 27.7% | 20.3% | 21.1% | 10.4% | 7.0% | 26.1% | 17.1% | -19.6% | -69.7% | -13.7% | 11.1% | |
| 7.4% | 9.1% | 7.5% | 6.4% | 2.4% | 2.1% | 6.7% | 4.7% | -0.7% | 2.8% | 4.6% | 4.1% | |
| 9.1% | 12.8% | 10.6% | 14.7% | 8.0% | 4.9% | 19.4% | 12.4% | -18.9% | -72.5% | -18.3% | 7.1% | |
| 30.1% | 38.1% | 27.2% | 31.1% | 19.8% | 23.4% | 38.6% | 28.4% | 1.4% | -4.5% | 5.1% | 32.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.